High expression level of geminin predicts a poor clinical outcome in salivary gland carcinomas

Histopathology

Volumn 56, Issue 7, 2010, Pages 883-892

  Yamazaki, Manabu ^a   Fujii, Satoshi ^a   Murata, Yukinori ^a   Hayashi, Ryuichi ^a   Ochiai, Atsushi ^a  

^a NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

Author keywords

Geminin; Ki67; Prognosis; Salivary gland carcinoma

Indexed keywords

GEMININ; KI 67 ANTIGEN; CELL CYCLE PROTEIN; GMNN PROTEIN, HUMAN;

ACINAR CELL CARCINOMA; ADENOID CYSTIC CARCINOMA; ADENOSQUAMOUS CARCINOMA; ADULT; ARTICLE; CANCER RELAPSE; CLINICAL ASSESSMENT; CLINICAL FEATURE; DISEASE MARKER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LARGE CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALIVARY GLAND CARCINOMA; STAINING; SURVIVAL RATE; TISSUE MICROARRAY; ADOLESCENT; AGED; CARCINOMA; LYMPH NODE METASTASIS; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; SALIVARY GLAND TUMOR; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CELL CYCLE PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; KI-67 ANTIGEN; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROGNOSIS; SALIVARY GLAND NEOPLASMS; SURVIVAL RATE; TISSUE ARRAY ANALYSIS; GEMININ; KAPLAN-MEIER ESTIMATE;

EID: 77953193049     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2010.03561.x     Document Type: Article

References (39)

1. US Cancer Statistics Working Group, ed. United States Cancer Statistics: 1999 Incidence.
2. Barnes L, Eveson JW, Reichart P, Sidransky D, eds. World Health Organization classification of tumours. Pathology and genetics tumours of head and neck.
3. Ellis GL, Auclair PL. Tumors of the salivary glands.
4. Goode RK, Auclair PL, Ellis GL. Mucoepidermoid carcinoma of the major salivary glands: clinical and histopathologic analysis of 234 cases with evaluation of grading criteria. Cancer 1998 82 1217 1224.
5. Brandwein MS, Ivanov K, Wallace DI et al. Mucoepidermoid carcinoma: a clinicopathologic study of 80 patients with special reference to histological grading. Am. J. Surg. Pathol. 2001 25 835 845.
6. Szanto PA, Luna MA, Tortoledo ME, White RA. Histologic grading of adenoid cystic carcinoma of the salivary glands. Cancer 1984 54 1062 1069.
7. Batsakis JG, Luna MA, el-Naggar A. Histopathologic grading of salivary gland neoplasms: III. Adenoid cystic carcinomas. Ann. Otol. Rhinol. Laryngol. 1990 99 1007 1009.
8. Terhaard CH, Lubsen H, Van der Tweel I et al. Salivary gland carcinoma: independent prognostic factors for locoregional control, distant metastases, and overall survival: results of the Dutch head and neck oncology cooperative group. Head Neck 2004 26 681 692 discussion 692-683.
9. Luukkaa H, Klemi P, Leivo I et al. Salivary gland cancer in Finland 1991-96: an evaluation of 237 cases. Acta Otolaryngol. 2005 125 207 214.
10. Luukkaa H, Klemi P, Leivo I, Vahlberg T, Grenman R. Prognostic significance of Ki-67 and p53 as tumor markers in salivary gland malignancies in Finland: an evaluation of 212 cases. Acta Oncol. 2006 45 669 675.
11. Ettl T, Schwarz S, Kleinsasser N, Hartmann A, Reichert TE, Driemel O. Overexpression of EGFR and absence of C-KIT expression correlate with poor prognosis in salivary gland carcinomas. Histopathology 2008 53 567 577.
12. Hellquist HB, Sundelin K, Di Bacco A, Tytor M, Manzotti M, Viale G. Tumour growth fraction and apoptosis in salivary gland acinic cell carcinomas. Prognostic implications of Ki-67 and bcl-2 expression and of in situ end labelling (TUNEL). J. Pathol. 1997 181 323 329.
13. Skalova A, Leivo I, Von Boguslawsky K, Saksela E. Cell proliferation correlates with prognosis in acinic cell carcinomas of salivary gland origin. Immunohistochemical study of 30 cases using the MIB 1 antibody in formalin-fixed paraffin sections. J. Pathol. 1994 173 13 21. (Pubitemid 24182256)
14. Skalova A, Lehtonen H, von Boguslawsky K, Leivo I. Prognostic significance of cell proliferation in mucoepidermoid carcinomas of the salivary gland: clinicopathological study using MIB 1 antibody in paraffin sections. Hum. Pathol. 1994 25 929 935. (Pubitemid 24292411)
15. Yin HF, Okada N, Takagi M. Apoptosis and apoptotic-related factors in mucoepidermoid carcinoma of the oral minor salivary glands. Pathol. Int. 2000 50 603 609.
16. Okabe M, Inagaki H, Murase T, Inoue M, Nagai N, Eimoto T. Prognostic significance of p27 and Ki-67 expression in mucoepidermoid carcinoma of the intraoral minor salivary gland. Mod. Pathol. 2001 14 1008 1014.
17. Kiyoshima T, Shima K, Kobayashi I et al. Expression of p53 tumor suppressor gene in adenoid cystic and mucoepidermoid carcinomas of the salivary glands. Oral Oncol. 2001 37 315 322.
18. Nordgard S, Franzen G, Boysen M, Halvorsen TB. Ki-67 as a prognostic marker in adenoid cystic carcinoma assessed with the monoclonal antibody MIB1 in paraffin sections. Laryngoscope 1997 107 531 536.
19. Xin W, Paulino AF. Prognostic factors in malignant mixed tumors of the salivary gland: correlation of immunohistochemical markers with histologic classification. Ann. Diagn. Pathol. 2002 6 205 210.
20. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J. Immunol. 1984 133 1710 1715.
21. Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J. Cell. Physiol. 2000 182 311 322.
22. Brown DC, Gatter KC. Ki67 protein: the immaculate deception? Histopathology 2002 40 2 11.
23. Pich A, Chiusa L, Navone R. Prognostic relevance of cell proliferation in head and neck tumors. Ann. Oncol. 2004 15 1319 1329.
24. Wohlschlegel JA, Kutok JL, Weng AP, Dutta A. Expression of geminin as a marker of cell proliferation in normal tissues and malignancies. Am. J. Pathol. 2002 161 267 273.
25. Takeda DY, Dutta A. DNA replication and progression through S phase. Oncogene 2005 24 2827 2843.
26. McGarry TJ, Kirschner MW. Geminin, an inhibitor of DNA replication, is degraded during mitosis. Cell 1998 93 1043 1053.
27. Wohlschlegel JA, Dwyer BT, Dhar SK, Cvetic C, Walter JC, Dutta A. Inhibition of eukaryotic DNA replication by geminin binding to Cdt1. Science 2000 290 2309 2312.
28. Gonzalez MA, Tachibana KE, Chin SF et al. Geminin predicts adverse clinical outcome in breast cancer by reflecting cell-cycle progression. J. Pathol. 2004 204 121 130.
29. Dudderidge TJ, Stoeber K, Loddo M et al. Mcm2, Geminin, and KI67 define proliferative state and are prognostic markers in renal cell carcinoma. Clin. Cancer Res. 2005 11 2510 2517.
30. Dudderidge TJ, McCracken SR, Loddo M et al. Mitogenic growth signalling, DNA replication licensing, and survival are linked in prostate cancer. Br. J. Cancer 2007 96 1384 1393.
31. Sobin LH, Wittekind C, eds. TNM classification of malignant tumours, 6th edn.
32. Wharton SB, Hibberd S, Eward KL et al. DNA replication licensing and cell cycle kinetics of oligodendroglial tumours. Br. J. Cancer 2004 91 262 269.
33. Vargas PA, Cheng Y, Barrett AW, Craig GT, Speight PM. Expression of Mcm-2, Ki-67 and geminin in benign and malignant salivary gland tumours. J. Oral Pathol. Med. 2008 37 309 318.
34. Chen AM, Bucci MK, Weinberg V et al. Adenoid cystic carcinoma of the head and neck treated by surgery with or without postoperative radiation therapy: prognostic features of recurrence. Int. J. Radiat. Oncol. Biol. Phys. 2006 66 152 159.
35. Chen AM, Garcia J, Bucci MK, Quivey JM, Eisele DW. The role of postoperative radiation therapy in carcinoma ex pleomorphic adenoma of the parotid gland. Int. J. Radiat. Oncol. Biol. Phys. 2007 67 138 143.
36. Raybaud-Diogene H, Fortin A, Morency R, Roy J, Monteil RA, Tetu B. Markers of radioresistance in squamous cell carcinomas of the head and neck: a clinicopathologic and immunohistochemical study. J. Clin. Oncol. 1997 15 1030 1038.
37. Grabenbauer GG, Muhlfriedel C, Rodel F et al. Squamous cell carcinoma of the oropharynx: Ki-67 and p53 can identify patients at high risk for local recurrence after surgery and postoperative radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 2000 48 1041 1050.
38. Couture C, Raybaud-Diogene H, Tetu B et al. p53 and Ki-67 as markers of radioresistance in head and neck carcinoma. Cancer 2002 94 713 722.
39. Shrestha P, Saito T, Hama S et al. Geminin: a good prognostic factor in high-grade astrocytic brain tumors. Cancer 2007 109 949 956.